JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.29% |
| 2 | Technology | 12.89% |
| 3 | Financials | 12.24% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
I
3701
PUT
DELISTED
INTELSAT S. A.
I
| $969K | ﹤0.01% |
+42,500
| New | +$897K |
2019 Q3
0 quarters
|
|
3702
Amneal Pharmaceuticals
AMRX
$6.99B
| $968K | ﹤0.01% |
333,889
+283,853
| +567% | +$990K |
2018 Q2
5 quarters
|
|
|
CTXS
3703
CALL
DELISTED
Citrix Systems Inc
CTXS
| $965K | ﹤0.01% |
10,000
| – | – |
2018 Q2
5 quarters
|
|
|
CTXS
3704
PUT
DELISTED
Citrix Systems Inc
CTXS
| $965K | ﹤0.01% |
10,000
| – | – |
2018 Q2
5 quarters
|
|
|
RDUS
3705
DELISTED
Radius Health, Inc.
RDUS
| $965K | ﹤0.01% |
37,504
-4,263
| -10% | -$104K |
2014 Q2
21 quarters
|
|
3706
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.3B
| $962K | ﹤0.01% |
14,244
-6,501
| -31% | -$441K |
2013 Q2
25 quarters
|
|
3707
Camtek
CAMT
$7.18B
| $961K | ﹤0.01% |
102,423
-30,982
| -23% | -$283K |
2018 Q2
5 quarters
|
|
3708
PUT
Evolus
EOLS
$508M
| $940K | ﹤0.01% |
60,200
+25,400
| +73% | +$416K |
2019 Q1
2 quarters
|
|
3709
Northeast Bank
NBN
$1.07B
| $939K | ﹤0.01% |
42,374
+9,916
| +31% | +$211K |
2016 Q4
11 quarters
|
|
3710
Manchester United
MANU
$3.56B
| $934K | ﹤0.01% |
56,843
+23,920
| +73% | +$421K |
2016 Q1
14 quarters
|
|
3711
Hingham Institution for Saving
HIFS
$624M
| $932K | ﹤0.01% |
4,933
+1,128
| +30% | +$214K |
2016 Q3
12 quarters
|
|
|
WAIR
3712
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $927K | ﹤0.01% |
84,182
+69,554
| +475% | +$754K |
2017 Q4
7 quarters
|
|
3713
Inovio Pharmaceuticals
INO
$125M
| $925K | ﹤0.01% |
37,622
+2,254
| +6% | +$68.5K |
2014 Q3
20 quarters
|
|
3714
Red Robin
RRGB
$142M
| $925K | ﹤0.01% |
27,803
-2,422
| -8% | -$79.5K |
2016 Q4
11 quarters
|
|
|
SHOE
3715
Shoe Station Group
SHOE
$345M
| $925K | ﹤0.01% |
57,064
-16,002
| -22% | -$222K |
2016 Q4
11 quarters
|
|
3716
CALL
SiriusXM
SIRI
$8.64B
| $922K | ﹤0.01% |
14,740
-135,000
| -90% | -$8.3M |
2018 Q2
5 quarters
|
|
3717
CALL
United Rentals
URI
$64.4B
| $922K | ﹤0.01% |
+7,400
| New | +$897K |
2019 Q3
0 quarters
|
|
3718
Vanguard Consumer Staples ETF
VDC
$7.46B
| $922K | ﹤0.01% |
5,889
-32
| -0.5% | -$4.92K |
2015 Q4
15 quarters
|
|
3719
Axsome Therapeutics
AXSM
$9.54B
| $921K | ﹤0.01% |
45,491
+38,802
| +580% | +$997K |
2019 Q2
1 quarter
|
|
3720
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.55B
| $918K | ﹤0.01% |
29,580
-12,510
| -30% | -$382K |
2013 Q2
25 quarters
|
|
|
YMAB
3721
DELISTED
Y-mAbs Therapeutics
YMAB
| $917K | ﹤0.01% |
35,196
+2,007
| +6% | +$51.3K |
2018 Q3
4 quarters
|
|
|
CNCE
3722
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $915K | ﹤0.01% |
155,637
+5,045
| +3% | +$53.5K |
2017 Q4
7 quarters
|
|
|
CLVS
3723
DELISTED
Clovis Oncology, Inc.
CLVS
| $915K | ﹤0.01% |
232,643
-107,244
| -32% | -$868K |
2013 Q2
25 quarters
|
|
3724
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.71B
| $914K | ﹤0.01% |
14,002
-400,260
| -97% | -$26M |
2018 Q4
3 quarters
|
|
3725
Vera Bradley
VRA
$143M
| $914K | ﹤0.01% |
90,477
-86,542
| -49% | -$915K |
2016 Q2
13 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,786 increased, 1,863 reduced and 426 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 426 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.